Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

361 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study.
Villani A, Shore A, Wasserman JD, Stephens D, Kim RH, Druker H, Gallinger B, Naumer A, Kohlmann W, Novokmet A, Tabori U, Tijerin M, Greer ML, Finlay JL, Schiffman JD, Malkin D. Villani A, et al. Among authors: malkin d. Lancet Oncol. 2016 Sep;17(9):1295-305. doi: 10.1016/S1470-2045(16)30249-2. Epub 2016 Aug 5. Lancet Oncol. 2016. PMID: 27501770
p53 and the Li-Fraumeni syndrome.
Malkin D. Malkin D. Biochim Biophys Acta. 1994 Dec 30;1198(2-3):197-213. doi: 10.1016/0304-419x(94)90014-0. Biochim Biophys Acta. 1994. PMID: 7819275 Review. No abstract available.
p53 and the Li-Fraumeni syndrome.
Malkin D. Malkin D. Cancer Genet Cytogenet. 1993 Apr;66(2):83-92. doi: 10.1016/0165-4608(93)90233-c. Cancer Genet Cytogenet. 1993. PMID: 8500106 Review.
The role of p53 in human cancer.
Malkin D. Malkin D. J Neurooncol. 2001 Feb;51(3):231-43. doi: 10.1023/a:1010636426860. J Neurooncol. 2001. PMID: 11407595 Review.
Germ line BAX alterations are infrequent in Li-Fraumeni syndrome.
Barlow JW, Mous M, Wiley JC, Varley JM, Lozano G, Strong LC, Malkin D. Barlow JW, et al. Among authors: malkin d. Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1403-6. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15298965
TP53 mutations and outcome in osteosarcoma: a prospective, multicenter study.
Wunder JS, Gokgoz N, Parkes R, Bull SB, Eskandarian S, Davis AM, Beauchamp CP, Conrad EU, Grimer RJ, Healey JH, Malkin D, Mangham DC, Rock MJ, Bell RS, Andrulis IL. Wunder JS, et al. Among authors: malkin d. J Clin Oncol. 2005 Mar 1;23(7):1483-90. doi: 10.1200/JCO.2005.04.074. J Clin Oncol. 2005. PMID: 15735124
361 results